Title: Treatment of perimenstrual migraine with triptans: an update.
Journal: Current pain and headache reports 20121001
Title: Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study.
Journal: The journal of headache and pain 20120701
Title: Stability, responsiveness, and reproducibility of a visual analog scale for treatment satisfaction in migraine.
Journal: Headache 20120601
Title: Cost-effectiveness analysis of early versus non-early intervention in acute migraine based on evidence from the 'Act when Mild' study.
Journal: Applied health economics and health policy 20120501
Title: Oral sumatriptan and almotriptan--delimiting the MAOI effect.
Journal: Headache 20120501
Title: LC-ESI-MS/MS determination of in vivo metabolites of almotriptan in rat plasma, urine and feces: application to pharmacokinetics.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120401
Title: The impact of allodynia on the efficacy of almotriptan when given early in migraine: data from the 'Act when mild' study.
Journal: The International journal of neuroscience 20111201
Title: Effect of iontophoresis on in vitro transdermal absorption of almotriptan.
Journal: International journal of pharmaceutics 20110915
Title: Almotriptan for menstrually related migraine.
Journal: Expert opinion on pharmacotherapy 20110801
Title: A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine.
Journal: The journal of headache and pain 20110601
Title: Improved patient satisfaction and pain evolution with almotriptan in migraine: a primary care study.
Journal: Current medical research and opinion 20110301
Title: Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.
Journal: Cephalalgia : an international journal of headache 20110101
Title: Almotriptan for the acute treatment of adolescent migraine.
Journal: Expert opinion on pharmacotherapy 20101001
Title: Almotriptan: a review of 10 years' clinical experience.
Journal: Expert review of neurotherapeutics 20101001
Title: Almotriptan efficacy in migraine with allodynia: a rebuttal to Burstein and Jakubowski's critique of Schoenen et al.
Journal: Cephalalgia : an international journal of headache 20100901
Title: Influence of trigger factors on the efficacy of almotriptan as early intervention for the treatment of acute migraine in a primary care setting: the START study.
Journal: Expert review of neurotherapeutics 20100901
Title: Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20100601
Title: Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the START study.
Journal: International journal of clinical practice 20100601
Title: Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents.
Journal: Headache 20100501
Title: Drug dependence associated with triptans and ergot derivatives: a case/non-case study.
Journal: European journal of clinical pharmacology 20100401
Title: Almotriptan for the treatment of acute migraine: a review of early intervention trials.
Journal: Expert review of neurotherapeutics 20100301
Title: [Acute migraine: a treatment reserved for adults now recommended for adolescents].
Journal: Perspective infirmiere : revue officielle de l'Ordre des infirmieres et infirmiers du Quebec 20100101
Title: Almotriptan efficacy in migraine with allodynia: a critique of Schoenen et al.
Journal: Cephalalgia : an international journal of headache 20091001
Title: Variation in almotriptan effectiveness according to different prophylactic treatments.
Journal: Headache 20091001
Title: Migraine treatment with rizatriptan and almotriptan: a crossover study.
Journal: Headache 20090501
Title: [Almotriptan vs. ergotamine plus caffeine for acute migraine treatment. A cost-efficacy analysis].
Journal: Neurologia (Barcelona, Spain) 20090401
Title: Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention.
Journal: Headache 20090301
Title: Almotriptan efficacy in migraine with developing allodynia is as high as the efficacy in migraine without allodynia--but is it the same in migraine with established allodynia?
Journal: Headache 20090301
Title: Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial.
Journal: Headache 20081001
Title: Almotriptan and its combination with aceclofenac for migraine attacks: a study of efficacy and the influence of auto-evaluated brush allodynia.
Journal: Cephalalgia : an international journal of headache 20081001
Title: Seizure after use of almotriptan.
Journal: Clinical neurology and neurosurgery 20080901
Title: Almotriptan in triptan-naïve patients: new evidence of benefits.
Journal: Cephalalgia : an international journal of headache 20080901
Title: The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
Journal: Cephalalgia : an international journal of headache 20080901
Title: Applying the benefits of the AwM study in the clinic.
Journal: Cephalalgia : an international journal of headache 20080901
Title: Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan.
Journal: Cephalalgia : an international journal of headache 20080401
Title: A validated reversed phase HPLC method for the determination of process-related impurities in almotriptan malate API.
Journal: Journal of pharmaceutical and biomedical analysis 20080313
Title: Migraine-like headache in intracranial haemorrhage is alleviated by sumatriptan and almotriptan.
Journal: Cephalalgia : an international journal of headache 20080301
Title: Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
Journal: Headache 20080301
Title: Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Journal: Headache 20080201
Title: Almotriptan, an antimigraine agent, and its malate salt.
Journal: Acta crystallographica. Section C, Crystal structure communications 20080101
Title: Almotriptan: meeting today's needs in acute migraine treatment.
Journal: Expert review of neurotherapeutics 20071201
Title: Use of almotriptan in triptan-experienced and triptan-naïve patients.
Journal: Current medical research and opinion 20071001
Title: Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.
Journal: Headache 20070901
Title: Do 5HT1B/1D receptor agonists have an effect on mood and anxiety disorders?
Journal: Cephalalgia : an international journal of headache 20070501
Title: Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
Journal: Headache 20070401
Title: Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy.
Journal: European journal of neurology 20070301
Title: Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Journal: Headache 20070201
Title: Patient preference in migraine therapy. A randomized, open-label, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptan.
Journal: Journal of neurology 20070201
Title: Almotriptan and zolmitriptan in the acute treatment of migraine.
Journal: Acta neurologica Scandinavica 20070101
Title: A pharmacoeconomic evaluation of oral triptans in the treatment of migraine in Italy.
Journal: Minerva medica 20061201
Title: Disposition and metabolism of almotriptan in rats, dogs and monkeys.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20060901
Title: Ethanol does not significantly affect the bioavailability of almotriptan: an open, randomized, crossover, single-dose, phase I clinical trial in healthy volunteers.
Journal: International journal of clinical pharmacology and therapeutics 20060901
Title: Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20060501
Title: Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials.
Journal: Cephalalgia : an international journal of headache 20060401
Title: Effect of food intake on the bioavailability of almotriptan, an antimigraine compound, in healthy volunteers: an open, randomized, crossover, single-dose clinical trial.
Journal: International journal of clinical pharmacology and therapeutics 20060401
Title: Almotriptan in the acute treatment of migraine in patients 11-17 years old: an open-label pilot study of efficacy and safety.
Journal: The journal of headache and pain 20060401
Title: [Economic evaluation of acute migraine attack treatment with triptans in Spain].
Journal: Neurologia (Barcelona, Spain) 20060301
Title: Value of postmarketing surveillance studies in achieving a complete picture of antimigraine agents: using almotriptan as an example.
Journal: The journal of headache and pain 20060201
Title: Evaluation of efficacy, tolerability, and treatment satisfaction with almotriptan in 3 consecutive migraine attacks. The migraine--satisfaction with treatment: reality with Almogran study.
Journal: European neurology 20060101
Title: Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.
Journal: International journal of clinical practice 20051101
Title: Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Journal: Current medical research and opinion 20051001
Title: Multiple attack study on the available triptans in Italy versus placebo.
Journal: European journal of neurology 20050701
Title: Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice.
Journal: Headache 20050601
Title: Effects of symptomatic treatments on cutaneous hyperalgesia and laser evoked potentials during migraine attack.
Journal: Cephalalgia : an international journal of headache 20050501
Title: Early triptan intervention in migraine: an overview.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20050501
Title: Correlation between lipophilicity and triptan outcomes.
Journal: Headache 20050101
Title: [Tolerance to almotriptan and its effectiveness in primary care].
Journal: Atencion primaria 20050101
Title: Clinical pharmacokinetics of almotriptan, a serotonin 5-HT(1B/1D) receptor agonist for the treatment of migraine.
Journal: Clinical pharmacokinetics 20050101
Title: Efficacy and tolerability of almotriptan in controlled clinical trials.
Journal: European neurology 20050101
Title: Efficacy and tolerability of almotriptan in postmarketing surveillance studies.
Journal: European neurology 20050101
Title: Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Journal: European neurology 20050101
Title: Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Journal: Headache 20050101
Title: Pharmacokinetics and safety of oral almotriptan in healthy male volunteers.
Journal: Biopharmaceutics & drug disposition 20041001
Title: Evaluating triptan usage: a rebuttal.
Journal: Headache 20041001
Title: TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management.
Journal: Acta neurologica Scandinavica 20040901
Title: [Meta-analysis of triptan treatment in migraine].
Journal: No to shinkei = Brain and nerve 20040901
Title: Meta-analysis of oral triptans.
Journal: Cephalalgia : an international journal of headache 20040801
Title: Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20040701
Title: [Almotriptan. One more triptan for migraines].
Journal: Revue de l'infirmiere 20040601
Title: Oral almotriptan: practical uses in the acute treatment of migraine.
Journal: Expert review of neurotherapeutics 20040501
Title: A comparison of the pharmacokinetics and tolerability of the anti-migraine compound almotriptan in healthy adolescents and adults.
Journal: Cephalalgia : an international journal of headache 20040401
Title: Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
Journal: Headache 20040401
Title: Evaluating triptan usage.
Journal: Headache 20040201
Title: A comparison of the cost-effectiveness of almotriptan and sumatriptan in the treatment of acute migraine using a composite efficacy/tolerability end point.
Journal: Journal of managed care pharmacy : JMCP 20040101
Title: Migraine pathophysiology and its clinical implications.
Journal: Cephalalgia : an international journal of headache 20040101
Title: What do patients want from acute migraine treatment?
Journal: Cephalalgia : an international journal of headache 20040101
Title: Clinical profile and practice experience of almotriptan.
Journal: Cephalalgia : an international journal of headache 20040101
Title: Clinical benefits of early triptan therapy for migraine.
Journal: Cephalalgia : an international journal of headache 20040101
Title: Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine.
Journal: Clinical therapeutics 20031101
Title: A review of the clinical efficacy and tolerability of almotriptan in acute migraine.
Journal: Expert opinion on pharmacotherapy 20030701
Title: Identification of the human liver enzymes involved in the metabolism of the antimigraine agent almotriptan.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20030401
Title: Interaction between ketoconazole and almotriptan in healthy volunteers.
Journal: Journal of clinical pharmacology 20030401
Title: A case of carotidynia with response to almotriptan.
Journal: Cephalalgia : an international journal of headache 20030301
Title: A review of the effects of almotriptan and other triptans on clinical trial outcomes that are meaningful to patients with migraine.
Journal: Clinical therapeutics 20030201
Title: [Almotriptan in the treatment of migraine attacks in clinical practice: results of the TEA 2000 observational study].
Journal: Neurologia (Barcelona, Spain) 20030101
Title: Almotriptan versus rizatriptan in patients with migraine in Spain.
Journal: Headache 20030101
Title: Early intervention with almotriptan improves sustained pain-free response in acute migraine.
Journal: Headache 20030101
Title: Almotriptan: an effective and well-tolerated treatment for migraine pain.
Journal: Drugs of today (Barcelona, Spain : 1998) 20030101
Title: Absolute bioavailability, pharmacokinetics, and urinary excretion of the novel antimigraine agent almotriptan in healthy male volunteers.
Journal: Journal of clinical pharmacology 20021201
Title: Efficacy and safety of almotriptan malate for migraine.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20021115
Title: New medications show promise for migraine sufferers.
Journal: Dentistry today 20021001
Title: Mechanisms of action of the 5-HT1B/1D receptor agonists.
Journal: Archives of neurology 20020701
Title: Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial.
Journal: Cephalalgia : an international journal of headache 20020701
Title: New drugs 2002, part III.
Journal: Nursing 20020701
Title: Use of rescue medication in trials of almotriptan versus placebo in the treatment of acute migraine.
Journal: Clinical therapeutics 20020401
Title: Triptan medications to treat acute migraine.
Journal: Lancet (London, England) 20020330
Title: Triptan medications to treat acute migraine.
Journal: Lancet (London, England) 20020330
Title: Triptan medications to treat acute migraine.
Journal: Lancet (London, England) 20020330
Title: Cardiovascular effect of almotriptan in treated hypertensive patients.
Journal: Clinical pharmacology and therapeutics 20020301
Title: Almotriptan (Axert) and frovatriptan (Frova) for migrane.
Journal: The Medical letter on drugs and therapeutics 20020218
Title: Cost savings in migraine associated with less chest pain on new triptan therapy.
Journal: The American journal of managed care 20020201
Title: Almotriptan: a review of pharmacology, clinical efficacy, and tolerability.
Journal: The American journal of managed care 20020201
Title: Health outcomes evaluations: estimating the impact of almotriptan in managed care settings.
Journal: The American journal of managed care 20020201
Title: Almotriptan versus sumatriptan in migraine treatment: direct medical costs of managing adverse chest symptoms.
Journal: The American journal of managed care 20020201
Title: How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials.
Journal: Headache 20020201
Title: [Treatment of migraine in patients with hypertension and ischemic heart disease].
Journal: Ideggyogyaszati szemle 20020120
Title: Almotriptan: a review of its use in migraine.
Journal: Drugs 20020101
Title: Almotriptan reduces the incidence of migraine-associated symptoms: a pooled analysis.
Journal: Headache 20020101
Title: Almotriptan increases pain-free status in patients with acute migraine treated in placebo-controlled clinical trials.
Journal: Headache 20020101
Title: Impact of chest pain on cost of migraine treatment with almotriptan and sumatriptan.
Journal: Headache 20020101
Title: Almotriptan increases sustained pain-free outcomes in acute migraine: results from three controlled clinical trials.
Journal: Headache 20020101
Title: Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the better.
Journal: Headache 20020101
Title: A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine.
Journal: Headache 20020101
Title: Spotlight on almotriptan in migraine.
Journal: CNS drugs 20020101
Title: Almotriptan, a new anti-migraine agent: a review.
Journal: CNS drug reviews 20020101
Title: Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine.
Journal: Neurology 20011127
Title: Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
Journal: Lancet (London, England) 20011117
Title: Efficacy and tolerability of subcutaneous almotriptan for the treatment of acute migraine: a randomized, double-blind, parallel-group, dose-finding study.
Journal: Clinical therapeutics 20011101
Title: Vascular effects of the new anti-migraine agent almotriptan on human cranial and peripheral arteries.
Journal: Cephalalgia : an international journal of headache 20011001
Title: Safety profile of almotriptan, a new antimigraine agent. Effects on central nervous system, renal function and respiratory dynamics.
Journal: Arzneimittel-Forschung 20010901
Title: [Migraine headache. Severe attacks: triptans are essential].
Journal: MMW Fortschritte der Medizin 20010719
Title: Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans).
Journal: Archives of neurology 20010701
Title: Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparison.
Journal: Archives of neurology 20010601
Title: Oral almotriptan in the treatment of migraine: safety and tolerability.
Journal: Headache 20010501
Title: Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans.
Journal: British journal of clinical pharmacology 20010501
Title: [Current topics: expectation for new triptans].
Journal: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20010410
Title: Hemodynamic and electrocardiographic effects of almotriptan in healthy volunteers.
Journal: Journal of cardiovascular pharmacology 20010301
Title: Acute treatment of migraine and the role of triptans.
Journal: Current neurology and neuroscience reports 20010301
Title: Evaluation of the potential pharmacokinetic interaction between almotriptan and fluoxetine in healthy volunteers.
Journal: Journal of clinical pharmacology 20010201
Title: Almotriptan: a balanced approach to migraine.
Journal: Hospital medicine (London, England : 1998) 20010201
Title: Lack of pharmacokinetic interaction between the antimigraine compound, almotriptan, and propranolol in healthy volunteers.
Journal: Cephalalgia : an international journal of headache 20010201
Title: Long-term efficacy and safety of oral almotriptan: interim analysis of a 1-year open study.
Journal: Headache 20010101
Title: Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan.
Journal: Clinical therapeutics 20010101
Title: Tolerability and efficacy of almotriptan in the long-term treatment of migraine.
Journal: European neurology 20010101
Title: Almotriptan: pharmacological differences and clinical results.
Journal: Current medical research and opinion 20010101
Title: Comparative aspects of triptans in treating migraine.
Journal: Clinical cornerstone 20010101
Title: Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine.
Journal: European journal of pharmacology 20001220
Title: Cardiovascular safety profile of almotriptan, a new indolic derivative for the treatment of migraine.
Journal: European journal of pharmacology 20001220
Title: Bou J , et al. Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine. Eur J Pharmacol, 2000. 410(1): p. 33-41.
Title: Gras J, et al. Safety profile of almotriptan, a new antimigraine agent. Effects on central nervous system, renal function and respiratory dynamics. Arzneimittelforschung, 2001. 51(9): p. 726-32.
